Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

West NR., Hegazy AN., Owens BMJ., Bullers SJ., Linggi B., Buonocore S., Coccia M., Görtz D., This S., Stockenhuber K., Pott J., Friedrich M., Ryzhakov G., Baribaud F., Brodmerkel C., Cieluch C., Rahman N., Müller-Newen G., Owens RJ., Kühl AA., Maloy KJ., Plevy SE., Keshav S., Travis SPL., Powrie F.

DOI

10.1038/nm.4307

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2017-05-01T00:00:00+00:00

Volume

23

Pages

579 - 589

Total pages

10

Permalink More information Close